Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 9, 2022
Patent Application Number
16870006
Date Filed
May 8, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
CPC Code
Provided herein are diagnostic antibodies that bind to glucocorticoid-induced tumor necrosis factor receptor (GITR). Such antibodies are useful for methods of detecting the expression of GITR in biological samples, for example, tumor tissue, and identifying a cancer patient likely to respond to anti-GITR immunotherapy or predicting whether a cancer patient will respond to anti-GITR immunotherapy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
